Trastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer

The human epidermal growth factor receptor-2 (HER2)-targeted therapies have improved clinical outcomes for patients at any stage of HER2-positive breast cancer (BC). Trastuzumab, a monoclonal antibody that targets the HER2 receptor on BC cells, showed improved survival in metastatic BC (MBC). Howeve...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ajay Gogia, Jagdish Nigade, Chirag Desai, Babu K Govind, Chetan Deshmukh, Binay Swarup
Format:	Artigo
Idioma:	Inglês
Publicat:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2018-01-01
Col·lecció:	Indian Journal of Medical and Paediatric Oncology
Matèries:	Drug conjugate human epidermal growth factor receptor-2 metastatic breast cancer Trastuzumab emtansine
Accés en línia:	http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=1;spage=79;epage=87;aulast=Gogia
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!